Cargando…
Serum pentraxin 3 as a biomarker for prognosis of acute minor stroke due to large artery atherosclerosis
OBJECTIVES: Pentraxin 3 (PTX3) may reflect local inflammatory status in tissues and thus serve as a potential biomarker of inflammation. Here, we investigated the utility of serum PTX3 as an index for assessing the 90‐day prognosis of acute minor stroke patients. MATERIALS & METHODS: Acute minor...
Autores principales: | Zhang, Yan, Hu, Haijie, Liu, Chong, Wu, Juan, Zhou, Shanshan, Zhao, Tingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821624/ https://www.ncbi.nlm.nih.gov/pubmed/33210471 http://dx.doi.org/10.1002/brb3.1956 |
Ejemplares similares
-
Update on Biomarkers Associated with Large-Artery Atherosclerosis Stroke
por: Rosário, Madalena, et al.
Publicado: (2023) -
Serum Pentraxin-3 Level in Patients Who Underwent Coronary Angiography and Relationship with Coronary Atherosclerosis
por: Nerkiz, Polat, et al.
Publicado: (2015) -
Inflammatory Biomarkers in Atherosclerosis: Pentraxin 3 Can Become a Novel Marker of Plaque Vulnerability
por: Shindo, Akihiro, et al.
Publicado: (2014) -
Monocyte/High-Density Lipoprotein Ratio Predicts the Prognosis of Large Artery Atherosclerosis Ischemic Stroke
por: Li, Youyu, et al.
Publicado: (2021) -
Pentraxin 3, TNF-α, and LDL-C Are Associated With Carotid Artery Stenosis in Patients With Ischemic Stroke
por: Yi, Li, et al.
Publicado: (2020)